These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12910716)

  • 1. [Effects of NaBT and NSAIDs on colorectal adenoma-carcinoma cells].
    Zhang Z; Ouyang Q; Gan H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):544-5, 593. PubMed ID: 12910716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effects of butyrates and non-steroidal anti-inflammatory agents on HT-29 colonic carcinoma cells].
    Zhang Z; Ouyang Q; Gan H
    Zhonghua Nei Ke Za Zhi; 2002 Mar; 41(3):153-5. PubMed ID: 11940312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cyclooxygenase-2 with sodium butyrate and NSAIDs on colorectal adenoma/carcinoma cells.
    Zhang ZH; Ouyang Q; Gan HT
    World J Gastroenterol; 2004 Oct; 10(20):2954-7. PubMed ID: 15378772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells.
    Andrews J; Djakiew D; Krygier S; Andrews P
    Cancer Chemother Pharmacol; 2002 Oct; 50(4):277-84. PubMed ID: 12357301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.
    Williams JL; Borgo S; Hasan I; Castillo E; Traganos F; Rigas B
    Cancer Res; 2001 Apr; 61(8):3285-9. PubMed ID: 11309281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis.
    Shiff SJ; Koutsos MI; Qiao L; Rigas B
    Exp Cell Res; 1996 Jan; 222(1):179-88. PubMed ID: 8549662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
    Crew TE; Elder DJ; Paraskeva C
    Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human fetal colon cells and colon cancer cells respond differently to butyrate and PUFAs.
    Hofmanová J; Vaculová A; Koubková Z; Hýzd'alová M; Kozubík A
    Mol Nutr Food Res; 2009 May; 53 Suppl 1():S102-13. PubMed ID: 19156717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of polyunsaturated fatty acids and sodium butyrate during apoptosis in HT-29 human colon adenocarcinoma cells.
    Hofmanová J; Vaculová A; Lojek A; Kozubík A
    Eur J Nutr; 2005 Feb; 44(1):40-51. PubMed ID: 15309463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit colon cancer cell growth more potently than traditional NSAIDs: a general pharmacological property?
    Yeh RK; Chen J; Williams JL; Baluch M; Hundley TR; Rosenbaum RE; Kalala S; Traganos F; Benardini F; del Soldato P; Kashfi K; Rigas B
    Biochem Pharmacol; 2004 Jun; 67(12):2197-205. PubMed ID: 15163551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma relative to adenoma cell lines.
    Elder DJ; Hague A; Hicks DJ; Paraskeva C
    Cancer Res; 1996 May; 56(10):2273-6. PubMed ID: 8625297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinoma.
    He H; Xia HH; Wang JD; Gu Q; Lin MC; Zou B; Lam SK; Chan AO; Yuen MF; Kung HF; Wong BC
    Cancer; 2006 Mar; 106(6):1243-9. PubMed ID: 16444744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of butyrate with TNF-alpha during differentiation and apoptosis of colon epithelial cells: role of NF-kappaB activation.
    Hýzd'alová M; Hofmanová J; Pacherník J; Vaculová A; Kozubík A
    Cytokine; 2008 Oct; 44(1):33-43. PubMed ID: 18662886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit DNA synthesis and the growth of colon cancer cells in vitro.
    Dial EJ; Doyen JR; Lichtenberger LM
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):295-300. PubMed ID: 16032431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells.
    Onoda T; Ono T; Dhar DK; Yamanoi A; Fujii T; Nagasue N
    J Lab Clin Med; 2004 Apr; 143(4):207-16. PubMed ID: 15085079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-inhibition of cyclooxygenase-2 and dihydropyrimidine dehydrogenase by non-steroidal anti-inflammatory drugs in tumor cells and xenografts.
    Réti A; Pap E; Zalatnai A; Jeney A; Kralovánszky J; Budai B
    Anticancer Res; 2009 Aug; 29(8):3095-101. PubMed ID: 19661321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization of colon cancer cell lines to butyrate-mediated proliferation inhibition by combined application of indomethacin and nordihydroguaiaretic acid.
    Galfi P; Neogrady Z; Amberger A; Margreiter R; Csordas A
    Cancer Detect Prev; 2005; 29(3):276-85. PubMed ID: 15936596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acids reduce the apoptosis-inducing effects of sodium butyrate on human colon adenoma (AA/C1) cells: implications for colon carcinogenesis.
    McMillan L; Butcher S; Wallis Y; Neoptolemos JP; Lord JM
    Biochem Biophys Res Commun; 2000 Jun; 273(1):45-9. PubMed ID: 10873561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAPK (ERK2) kinase--a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth.
    Husain SS; Szabo IL; Pai R; Soreghan B; Jones MK; Tarnawski AS
    Life Sci; 2001 Nov; 69(25-26):3045-54. PubMed ID: 11758830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.